(134 days)
No
The summary describes a standard dental implant system and its mechanical testing. There is no mention of AI, ML, image processing, or any other technology typically associated with AI/ML in medical devices.
Yes
The device is described as "intended for surgical placement in mandibles or maxillae to support single or multiple tooth restorations or terminal or intermediate abutment support for fixed or removable bridgework and to retain overdentures," which is a therapeutic purpose.
No
Explanation: The device description clearly states that these are "endosseous dental implants, which are designed to support prosthetic devices". This indicates their function is for structural support and restoration, not for diagnosing conditions.
No
The device description explicitly states it is an "integrated system of endosseous dental implants" and includes "a variety of dental implants and related surgical instruments," which are physical hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for surgical placement in the body (mandibles or maxillae) to support dental restorations. This is an in vivo application, meaning it's used within a living organism.
- Device Description: The description details a system of endosseous dental implants and surgical instruments. These are physical devices implanted into the bone.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening.
IVD devices are used outside the body to analyze biological samples. This device is surgically implanted inside the body.
N/A
Intended Use / Indications for Use
Biodenta bone level tapered dental implants are intended for surgical placement in mandibles or maxillae to support single or multiple tooth restorations or terminal or intermediate abutment support for fixed or removable bridgework and to retain overdentures.
Product codes (comma separated list FDA assigned to the subject device)
DZE
Device Description
The Biodenta Dental Implant System - Bone Level Tapered is an integrated system of endosseous dental implants, which are designed to support prosthetic devices for partially or fully edentulous patients. The system consists of a variety of dental implants and related surgical instruments. The Bone Level Tapered implants use the same platforms and abutment connections like the Bone Level implants (K111003), and therefore the abutments and prosthetic parts of the Bone Level implants are used with the Bone Level Tapered implants.
The System includes dental implants with the following dimensions:
- Diameter 3.5 mm Implants with Length of: 8, 10, 12, and 14 mm; Platform B1
- Diameter 4.1 mm Implants with Length of: 8, 10, 12, and 14 mm; Platform B2
- Diameter 4.8 mm Implants with Length of: 8, 10, 12, and 14 mm; Platform B2
- Diameter 6.0 mm Implants with Length of: 8, 10, and 12 mm; Platform B2
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
mandibles or maxillae
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Fatigue testing was conducted according to FDA Guide: Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments -Guidance for Industry and FDA Staff and ISO 14801 Dentistry-Implants-Dynamic fatigue test for endosseous dental implants. The worst case scenario for the Biodenta Dental Implant System - Bone Level Tapered implants and abutments was tested. These results show that Biodenta Dental Implant System - Bone Level Tapered have sufficient mechanical strength for their intended clinical application.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Premarket Notification / 510(k) Submission Biodenta Dental Implant System - Bone Level Tapered 5 - 510(k) Summary
. . . . . .
.. .. ..
Image /page/0/Picture/2 description: The image shows the word "biodenta" in black font with a registered trademark symbol. Above the word is a curved design with three lines. The font is simple and easy to read. The logo is likely for a dental product or service.
0
510(k) Summary
| Owner's name: | Biodenta Swiss AG |
|---|---|
| Address: | Tramstrasse 16 |
| 9442 Berneck | |
| Switzerland | |
| Phone: | +41 71 747 11 11 |
| Fax number: | + 41 71 747 11 12 |
| Contact person: | Mr. David Eiler, Regulatory Manager |
| Date summary prepared: | Feb. 04, 2013 |
| Trade / proprietary name: | Biodenta Dental Implant System - Bone Level Tapered |
| Common name: | Endosseous dental implant |
| Device classification name: | implant, endosseous, root-form |
| Product code: | DZE |
| Regulation number: | 21 CFR 872.3640 |
Legally marketed device to which equivalence is claimed (predicate device):
| 1. Company: | Biodenta Swiss AG |
|---|---|
| Device name: | Biodenta Dental Implant System - Bone Level |
| 510(k) number: | K111003 |
| 2. Company: | Keystone Dental |
| Device name: | Genesis Implant System |
| 510(k) number: | K101545 |
2 0
5 0
101 Revision
Section Section page
1
Premarket Notification / 510(k) Submission Biodenta Dental Implant System - Bone Level Tapered 5 - 510(k) Summary
Image /page/1/Picture/2 description: The image shows the logo for "biodenta". The word "biodenta" is written in a bold, sans-serif font. Above the word "biodenta" is a graphic of three curved lines. To the right of the word "biodenta" is a circled R, which is the registered trademark symbol.
Indications for Use:
Biodenta bone level tapered dental implants are intended for surgical placement in mandibles or maxillae to support single or multiple tooth restorations or terminal or intermediate abutment support for fixed or removable bridgework and to retain overdentures.
Device Description:
The Biodenta Dental Implant System - Bone Level Tapered is an integrated system of endosseous dental implants, which are designed to support prosthetic devices for partially or fully edentulous patients. The system consists of a variety of dental implants and related surgical instruments. The Bone Level Tapered implants use the same platforms and abutment connections like the Bone Level implants (K111003), and therefore the abutments and prosthetic parts of the Bone Level implants are used with the Bone Level Tapered implants.
The System includes dental implants with the following dimensions:
- Diameter 3.5 mm Implants with Length of: 8, 10, 12, and 14 mm; Platform B1
- Diameter 4.1 mm Implants with Length of: 8, 10, 12, and 14 mm; Platform B2
- Diameter 4.8 mm Implants with Length of: 8, 10, 12, and 14 mm; Platform B2
- Diameter 6.0 mm Implants with Length of: 8, 10, and 12 mm; Platform B2
Non-clinical Testing Data:
Fatigue testing was conducted according to FDA Guide: Class II Special Controls Guidance Document: Root-form Endosseous Dental Implants and Endosseous Dental Abutments -Guidance for Industry and FDA Staff and ISO 14801 Dentistry-Implants-Dynamic fatigue test for endosseous dental implants. The worst case scenario for the Biodenta Dental Implant System - Bone Level Tapered implants and abutments was tested. These results show that Biodenta Dental Implant System - Bone Level Tapered have sufficient mechanical strength for their intended clinical application.
Equivalence to marketed device:
Biodenta Swiss AG demonstrated that, for the purposes of FDA's regulation of medical devices, the Biodenta Dental Implant System - Bone Level Tapered is substantially equivalent to the predicate devices in intended use, material composition, fundamental scientific technology, principles of operation, and basic design.
2
Premarket Notification / 510(k) Submission Biodenta Dental Implant System - Bone Level Tapered 5 - 510(k) Summary
Image /page/2/Picture/2 description: The image shows the logo for "biodenta". The logo consists of the word "biodenta" in a bold, sans-serif font, with a stylized graphic above it. The graphic appears to be three curved lines stacked on top of each other, resembling a stylized leaf or wave. A registered trademark symbol is present to the right of the word "biodenta".
Summary Substantial Equivalence Comparison to predicate devices:
| Subject Device | Predicate Devices | ||
|---|---|---|---|
| Device Name | Biodenta Dental Implant | ||
| System - Bone Level | |||
| Tapered | Biodenta Dental Implant | ||
| System - Bone Level | |||
| (K111003) | Genesis Implant System (K101545) | ||
| Intended Use | |||
| Intended use | Biodenta bone level tapered | ||
| dental implants are intended | |||
| for surgical placement in | |||
| mandibles or maxillae to | |||
| support single or multiple | |||
| tooth restorations or terminal | |||
| or intermediate abutment | |||
| support for fixed or | |||
| removable bridgework and to | |||
| retain overdentures. | Biodenta bone level dental | ||
| implants are intended for | |||
| surgical placement in | |||
| mandibles or maxillae to | |||
| support single or multiple | |||
| tooth restorations or | |||
| terminal or intermediate | |||
| abutment support for fixed | |||
| or removable bridgework | |||
| and to retain overdentures. | The Genesis Implant System is | ||
| intended for use in single-stage or | |||
| two-stage surgical procedures in all | |||
| types of bone in partially or fully | |||
| edentulous mandibles and maxillae. | |||
| The Genesis Implant System | |||
| supports single or multiple-unit | |||
| restorations to re-establish patient | |||
| chewing function and esthetics. | |||
| Genesis implants are intended for | |||
| placement following natural tooth | |||
| loss or for immediate placement into | |||
| an extraction socket. Immediate | |||
| function may be achieved when | |||
| good primary stability is established | |||
| and appropriate occlusal loading is | |||
| applied. | |||
| Basic Design | |||
| Implant Type | threaded, root form, bone | ||
| level implant | threaded, root form, bone | ||
| level implant | threaded, root form, | ||
| bone level implant | |||
| Implant Shape | Tapered | Straight | Tapered |
| (+ straight types) | |||
| Implants Diameter | |||
| (& Length) | 3.5 mm (8 - 14 mm) | ||
| 4.1 mm (8 - 14 mm) | |||
| 4.8 mm (8 - 14 mm) | |||
| 6.0 mm (8 - 12 mm) | 3.5 mm (8 - 14 mm) | ||
| 4.1 mm (8 - 14 mm) | |||
| 4.8 mm (8 - 14 mm) | Tapered Implants: | ||
| 3.8 mm (8.5 - 18 mm) | |||
| 4.5 mm (8.5 - 18 mm) | |||
| 5.5 mm (8.5 - 16 mm) | |||
| 6.5 mm (8.5 - 13 mm) | |||
| Straight Implants: | |||
| 3.8 mm (8.5 - 18 mm) | |||
| 4.5 mm (8.5 - 18 mm) | |||
| Implant to Abut. | |||
| Connection | Internal Hexagon | Internal Hexagon | Internal 6 lobe |
| Material | Titanium Grade 4 | Titanium Grade 4 | Titanium Grade 4 |
| Surface | |||
| Treatment | Spark Anodization | ||
| (uses same surface | |||
| modification as K111003) | Spark Anodization | Double-acit-etching & | |
| Spark Anodization | |||
| Abutment System | Angled and Straight | ||
| (uses same abutments as | |||
| K111003) | Angled and Straight | Angled and Straight | |
| Abutment Angle | 0°, 15° | 0°, 15° | 0°, 15° |
| Sterilization | |||
| (Implants) | Delivered Sterile Gamma | ||
| Irradiation | Delivered Sterile Gamma | ||
| Irradiation | Delivered Sterile | ||
| Gamma Irradiation |
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 19, 2013
Mr. David Eiler Regulatory Manager Biodenta Swiss AG Tramstrasse 16 Berneck, St. Gallen Switzerland 9442
Re: K123415
Trade/Device Name: Biodenta Dental Implant System - Bone Level Tapered Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE Dated: February 14, 2013 Received: February 19, 2013
Dear Mr. Eiler:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Image /page/4/Picture/7 description: The image shows the text "Kwame O. Ulmer for". The text "Kwame O. Ulmer" is in a larger, bolder font than the word "for". The letters "O.U." are stylized with a geometric pattern.
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Premarket Notification / 510(k) Submission Biodenta Dental Implant System - Bone Level Tapered 4 - Indications for Use Statement
Image /page/5/Picture/2 description: The image shows the word "biodenta" in a bold, sans-serif font. Above the word is a graphic element that looks like three curved lines stacked on top of each other. The lines are textured, giving the impression of a natural or organic material. To the right of the word "biodenta" is the registered trademark symbol, a capital R inside a circle.
Indications for Use
× 23415 510(k) Number (if known):
Device Name: Biodenta Dental Implant System - Bone Level Tapered
Indications for Use:
Biodenta bone level tapered dental implants are intended for surgical placement in mandibles or maxillae to support single or multiple tooth restorations or terminal or intermediate abutment support for fixed or removable bridgework and to retain overdentures.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Mary S. Runner -S 2013:03.14 07:55:10 -04'00'
Division Sign-Off) (Division Bign-Off)
Division of Anesthesiology, General Hospital Division of Antrol, Dental Devices
12341 510(k) Number;
Page 1 of 1
Revision ੱ ਹੋ Section ેને Section page 2 of 4.